Dr. Ngalulawa Kone

Ngalulawa Kone is a clinical laboratory scientist and researcher affiliated with the National Health Laboratory Service in South Africa, with collaborations across academic hospitals in Gauteng and the region. The research portfolio centers on diagnostic medicine, particularly the optimization of biochemical testing within public health systems in Southern Africa.

Key focus areas include diabetes management, cardiovascular risk assessment, lipid measurement methodologies, and endocrine tumor diagnostics. Work on HbA1c cut-offs in Zimbabwe and guideline adherence in South Africa has informed context-specific diabetes care, while comparative studies of LDL-C calculation formulae have strengthened laboratory decision-making in high-risk populations.

Contributions also extend to infectious disease surveillance, including SARS-CoV-2 seroprevalence studies, and earlier investigations in heart failure therapeutics. Across projects, emphasis is placed on cost-effective testing strategies, population health disparities, and evidence-based improvements to laboratory practice in resource-limited settings.